Duopharma Biotech Bhd (7148) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.033x

Based on the latest financial reports, Duopharma Biotech Bhd (7148) has a cash flow conversion efficiency ratio of 0.033x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM25.12 Million ≈ $6.31 Million USD) by net assets (RM757.35 Million ≈ $190.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Duopharma Biotech Bhd (7148) flexibility index to assess the company's free cash flow relative to its total liabilities.

Duopharma Biotech Bhd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Duopharma Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Duopharma Biotech Bhd (7148) total market value for the company's overall valuation and market capitalisation.

Duopharma Biotech Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Duopharma Biotech Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Newron Pharmaceuticals SpA
SW:NWRN
0.119x
Shiyan Taixiang Industry Co. Ltd. A
SHE:301192
0.026x
Parag Milk Foods Limited
NSE:PARAGMILK
0.079x
Wuhan Citms Technology Co Ltd
SHG:688038
-0.054x
Ser Educacional Sa
SA:SEER3
0.073x
Daelim Paper Co.Ltd
KQ:017650
0.018x
Sonda S.A
SN:SONDA
0.054x
Zhejiang Benli Technology Co. Ltd.
SHE:301065
N/A

Annual Cash Flow Conversion Efficiency for Duopharma Biotech Bhd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Duopharma Biotech Bhd from 2006 to 2025. View latest Duopharma Biotech Bhd stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM757.62 Million
≈ $190.21 Million
RM112.71 Million
≈ $28.30 Million
0.149x +28.40%
2024-12-31 RM709.15 Million
≈ $178.04 Million
RM82.16 Million
≈ $20.63 Million
0.116x +54.42%
2023-12-31 RM687.12 Million
≈ $172.51 Million
RM51.55 Million
≈ $12.94 Million
0.075x -30.04%
2022-12-31 RM655.22 Million
≈ $164.50 Million
RM70.27 Million
≈ $17.64 Million
0.107x +54.89%
2021-12-31 RM624.00 Million
≈ $156.67 Million
RM43.20 Million
≈ $10.85 Million
0.069x -37.52%
2020-12-31 RM643.82 Million
≈ $161.64 Million
RM71.35 Million
≈ $17.91 Million
0.111x -12.32%
2019-12-31 RM529.75 Million
≈ $133.00 Million
RM66.96 Million
≈ $16.81 Million
0.126x -15.94%
2018-12-31 RM481.04 Million
≈ $120.77 Million
RM72.33 Million
≈ $18.16 Million
0.150x +28.73%
2017-12-31 RM479.87 Million
≈ $120.48 Million
RM56.05 Million
≈ $14.07 Million
0.117x +59.71%
2016-12-31 RM454.52 Million
≈ $114.11 Million
RM33.24 Million
≈ $8.35 Million
0.073x +164.65%
2015-12-31 RM449.72 Million
≈ $112.91 Million
RM-50.88 Million
≈ $-12.77 Million
-0.113x -160.89%
2014-12-31 RM193.63 Million
≈ $48.61 Million
RM35.97 Million
≈ $9.03 Million
0.186x -14.16%
2013-12-31 RM182.65 Million
≈ $45.86 Million
RM39.53 Million
≈ $9.93 Million
0.216x -4.12%
2012-12-31 RM170.50 Million
≈ $42.81 Million
RM38.49 Million
≈ $9.66 Million
0.226x +91.65%
2011-12-31 RM164.44 Million
≈ $41.29 Million
RM19.37 Million
≈ $4.86 Million
0.118x -53.56%
2010-12-31 RM157.87 Million
≈ $39.64 Million
RM40.04 Million
≈ $10.05 Million
0.254x +33.09%
2009-12-31 RM142.74 Million
≈ $35.84 Million
RM27.20 Million
≈ $6.83 Million
0.191x -5.97%
2008-12-31 RM130.55 Million
≈ $32.78 Million
RM26.46 Million
≈ $6.64 Million
0.203x -7.77%
2007-12-31 RM114.21 Million
≈ $28.68 Million
RM25.10 Million
≈ $6.30 Million
0.220x +18.17%
2006-12-31 RM145.43 Million
≈ $36.51 Million
RM27.04 Million
≈ $6.79 Million
0.186x --

About Duopharma Biotech Bhd

KLSE:7148 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$297.06 Million
RM1.18 Billion MYR
Market Cap Rank
#14943 Global
#175 in Malaysia
Share Price
RM1.23
Change (1 day)
+0.00%
52-Week Range
RM1.19 - RM1.55
All Time High
RM2.86
About

Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives… Read more